title: Management strategies of Barrett's esophagus.
abstract: Barrett's esophagus is a condition resulting from chronic gastro-esophageal reflux disease with a documented risk of esophageal adenocarcinoma. Current strategies for improved survival in patients with Barrett's adenocarcinoma focus on detection of dysplasia. This can be obtained by screening programs in high-risk cohorts of patients and/or endoscopic biopsy surveillance of patients with known Barrett's esophagus (BE). Several therapies have been developed in attempts to reverse BE and reduce cancer risk. Aggressive medical management of acid reflux, lifestyle modifications, antireflux surgery, and endoscopic treatments have been recommended for many patients with BE. Whether these interventions are cost-effective or reduce mortality from esophageal cancer remains controversial. Current treatment requires combinations of endoscopic mucosal resection techniques to eliminate visible lesions followed by ablation of residual metaplastic tissue. Esophagectomy is currently indicated in multifocal high-grade neoplasia or mucosal Barrett's carcinoma which cannot be managed by endoscopic approach.
authors.affiliation: Department of General, Geriatric, Oncologic Surgery and Advanced Technologies, Center of Excellence for Technical Innovation in Surgery, University of Naples Federico II, 80131 Naples, Italy.
authors.forename: Giovanni D
authors.initials: GD
authors.lastname: De Palma
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D001471:Barrett Esophagus / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D005764:Gastroesophageal Reflux / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D011230:Precancerous Conditions / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors